Published
On a day when shares of Eli Lilly gained more than 5% thanks to strong demand for its weight-loss drugs, Summit Place Financial Advisors President Liz Miller wonders how long it and other pharmaceutical companies can continue to charge very high prices for these extremely popular treatments. Reuters' Lisa Bernhard has more.
#News #elililly #weightloss #Reuters #Newsfeed
Read the story here:
???? Subscribe: http://smarturl.it/reuterssubscribe
Keep up with the latest news from around the world: https://www.reuters.com/
Follow Reuters on Facebook: https://www.facebook.com/Reuters
Follow Reuters on Twitter: https://twitter.com/Reuters
Follow Reuters on Instagram: https://www.instagram.com/reuters/?hl=en
#News #elililly #weightloss #Reuters #Newsfeed
Read the story here:
???? Subscribe: http://smarturl.it/reuterssubscribe
Keep up with the latest news from around the world: https://www.reuters.com/
Follow Reuters on Facebook: https://www.facebook.com/Reuters
Follow Reuters on Twitter: https://twitter.com/Reuters
Follow Reuters on Instagram: https://www.instagram.com/reuters/?hl=en
- Category
- World
- Tags
- reuters, news, world news today
Sign in or sign up to post comments.
Be the first to comment
Up Next
Autoplay
-
08:00
Physician discusses surge in demand for weight-loss drugs and risks in using them
-
19:13
How Ozempic and other weight loss drugs are affecting our relationship with food | Extra Minutes
-
01:00
Weight-loss drugs Wegovy and Ozempic scrutinized over reports of suicide risk
-
22:54
Wegovy costs $400 a month. Should weight-loss drugs like Ozempic be covered? | The Current
-
02:36
New study suggest weight loss drugs may help lower risk of certain cancers
-
01:18
Annual sales of weight-loss drugs seen hitting $150 billion | REUTERS
-
02:13
As Ozempic use grows, poison centre calls in Canada jump for injectable weight-loss drugs
-
02:50
New FDA warning about 'off-brand' compounded forms of drugs used for weight loss
-
05:56
Americans willing to pay $100 monthly for weight-loss drugs: U.S. poll
-
Business Live: Novo Nordisk raises its forecasts fuelled by high demand for weight loss drugs
-
00:57
Celebrities slammed for using diabetes, weight loss drugs by Eli Lilly
-
08:45
How new weight loss drugs are changing the conversation around treating obesity
-
05:09
Sectors UpClose: Weight loss drugs are the 'new hype trade'
-
08:39
The many ways new weight loss drugs could transform the economy
-
01:18
Weight-loss drugs in tight supply, shortage could last through June
-
03:43
USING WEIGHT LOSS DRUGS?: Dr. Makary warns these may not be right for you
-
01:57
What are "Ozempic babies" and why are women reporting being pregnant while on weight-loss drugs?
-
07:27
Ozempic and Other Weight-Loss Drugs: How to Get Health Insurance to Pay | Your Money Briefing | WSJ
-
02:50
New study on drugs used for weight loss and counterfeit concerns
-
09:19
Weight loss patients seek more choices over new drugs | NTL
-
08:00
Demand For Off-Brand Weight Loss Drugs EXPLODES, But Are They SAFE?
-
02:40
Eli Lilly issues warning about potentially counterfeit weight loss drugs
Loading...